20190611-13: Immunoabsorption CNTN1/Caspr1(16047 1:250)

Objective: to do an immunoabsorption of CNTN1/Caspr1 in sera from 1 patient with antibodies anti-CNTN1/Caspr1 11.06.2019: Coating HEK293
  • Prepare 4  6-well plates
  • Treatment with Poly-D-Lysine (diluted 1/40 with boratte buffer)
  • Incubate for 1h (37ºC, 5% CO2).
  • Wash with PBS
  • Trypsin-EDTA a plate of HEK293 –> For every well: 240.000 cells
  • Incubate at 37ºC for 24h.

12.06.2019: Transfection

Transfect 3  6-well plate with CNTN1, Caspr1, CNTN1+Caspr1
  • CNTN1: DNA 4 µg /well; Lipofectamine 6 µL/well ; Optimen 250 µL/well
  • Caspr1: DNA 4 µg /well; Lipofectamine 6 µL/well ; Optimen 250 µL/well
  • CTNT1 DNA 4 µg /well (Caspr1 1.35 µL/well ; CNTN1 2,65 µL/well ); Lipofectamine 6 µL/well ; Optimen 250 µL/well
  • Incubate the DNA and the lipofectamine at RT for 5 min.
  • Unify every DNA with the appropriate amount of Lipo and incubate at RT for 30 min.
  • For every well: 2 ml of HEK medium and 250 µL of the mix of DNA and Lipo.
  • Incubate O/N at 37ºC.

13.06.2019 : Fixing and Immunoabsorption

  • Fix  with PFA 4%. Incubation at RT during 10min.
  • Wash with PBS 1x.
  • Dilute serum 1/250 in Goat 5%. Samples:
    • Sample: 16047
  • Put 0’5 ml in the first well of every plate :
  • 1. CNTN1
  • 2. Caspr1
  • 3. CNTN1/Caspr1
  • 4. Non-transfected cells
  • Incubate 1 hour in every well (at RT)
  • Freeze the immunoabsorpted samples at -20ºC
Note: serum preabsorbed with Caspr1 was only incubated in 3 wells 13.06.2019: Comprobation (teasing): (teasing protocol): Sample 16.047 1:250 pre-absorbed with: 1.CNTN1+Caspr1: NEGATIVE 2. CNTN1: POSITIVE 3. Caspr1: POSITIVE 4. NON-TRANSFECTED HEK: POSITIVE 5.CONTROL: 16047 1:250 non-absorbed: POSITIVE CONLUSION: Paranodal stainning patern disapeared when serum from patient 16.047 diluted 1:250 was preabsorbed with HEK transfected with CNTN1+Caspr1 but not when CNTN1 or Caspr1 were transfected alone.
Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.